Sagitta™ is a molecular diagnostic technology platform based on Real Time PCR inclusive of native multiplexing, capable of detecting and characterizing viral, bacterial and eukaryotic nucleic acids, even starting directly from non-purified biological samples.

Real Time PCR-based molecular assays represent the gold standard for most clinical laboratories around the world, thanks to their performance in terms of specificity, sensitivity and easy of use.

Through Sagitta™ platform, Ulisse Biomed offers affordable and reliable kits for the detection of a variety of pathogen.

Ulisse Biomed developed over its 10+ years of experience various proprietary technologies for multiplexing qPCR testing.

Our reagent technologies allow a wide range of kit formats and features, such as dry reagents stable at room temperature that improve user experience, logistic costs and overall product performance over time.

We apply our expertise nad prorpietary technologies to our own catalog of kits, and we make it available for clients and partners thourgh our custom devleopment services.